TearScience

Headquartered in Morrisville, North Carolina, TearScience has pioneered devices that provide significant clinical identification and treatment of evaporative dry eye. Of the 100 million plus of dry eye sufferers worldwide, the leading cause (86percent) is evaporative dry eye, which is caused by Meibomian Gland Dysfunction (MGD) and a lipid deficiency of the eye’s natural tear film. The Tear Film and Ocular Surface Society (TFOS) workshop, involving two years of work by 50 leading experts from around the world, concluded that MGD is an under-estimated condition and is very likely the most frequent cause of dry eye disease. Common symptoms of the disease include eye irritation, dryness, redness, tiredness, and visual disturbances. TearScience’s integrated, in-office system enables eye care professionals to effectively address a root cause of evaporative dry eye.
Type
Private
HQ
Morrisville, US
Founded
2005
Employees
82 (est)+2%

Key People at TearScience

Christy Mocny

Christy Mocny

Director, Quality Assurance & Regulatory Compliance
Steve Grenon

Steve Grenon

VP, Research & Development
Diethart Reichardt

Diethart Reichardt

SVP - European Region
Doug Pinotti

Doug Pinotti

GM, Asia Pacific & Latin America
Donald Korb

Donald Korb

CTO & Co - Founder
Wade Hampton

Wade Hampton

Chief Commercial Officer

TearScience Locations

Morrisville, US

TearScience Metrics

TearScience Summary

Founding Date

2005

Total Funding

$134 M

Latest funding size

$19.2 M

Time since last funding

8 months

Investors

TearScience Online Presence

TearScience Company Life